fowlpox

(redirected from Fowlpox virus)
Also found in: Dictionary, Wikipedia.

fowlpox

a slow-spreading disease of fowl and turkeys caused by the avian poxvirus and characterized by pox lesions on the skin of the head, and on the neck in turkeys. Involvement of eyelids causes lacrimation and accumulation of caseous material in the conjunctival sac. Lesions may also be present in the mouth, esophagus and upper respiratory tract. Transmitted by mosquitoes or by contact.
References in periodicals archive ?
Among a subset of 26 Henslow's sparrows from which blood samples were obtained, none had detectable antibody reactive to fowlpox virus antigen.
Caused by fowlpox virus (FWPV), the disease is primarily found in 2 forms, cutaneous and diphtheritic (2).
Detection of specific reticuloendotheliosis virus sequence and protein from REV-integrated fowlpox virus strains.
Integration of the reticuloendotheliosis virus envelope gene into the poultry fowlpox virus genome is not universal.
Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens.
ECOG 7897 is an ongoing Phase II clinical trial for the evaluation of a prime/boost vaccine strategy using vaccinia virus and fowlpox virus expressing human PSA in patients with hormone-dependent prostate cancer.
The ELISA or hemagglutination inhibition assay was used to test serum samples (N = 38) for antibodies against avian influenza virus, infectious bursal disease virus, fowlpox virus, and Newcastle disease virus.
We included both inactivated and recombinant fowlpox virus expressing H5 (rFPV-H5) vaccine studies that used specific-pathogen-free chickens where outcomes against the H5N1 or H5N2 AI viruses were measured.
In contrast, chickens in Galapagos were infected with a virus that appears to be identical in sequence to the characterized fowlpox virus and about 30% different from the canarypox/Galapagos group viruses in the regions sequenced.
Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens.
Virax's HIV vaccine trial will be a multi-centre, double blind, controlled, randomised, parallel group study in 36 patients to evaluate Virax's Co-X-GeneTM with fowlpox virus (FPV) technology in humans.
VectorVax FP-N, comprised of a fowlpox virus genetically designed to protect poultry against both fowlpox and Newcastle disease, is the first Category III biotechnology product to be approved by the USDA and the first commercially available viral vector vaccine for any species.